According to the American Academy of Allergy, Asthma and Immunology, about 34.1 million Americans have been diagnosed with asthma. The condition leads to 10.5 million visits to physician offices, 217,000 visits to emergency rooms, 500,000 hospitalizations, and 3,384 deaths every year. Asthma is annually responsible for 10.1 missed days from work and 12.8 missed days from school.

China, South Korea and Japan have several already and now the first in-patient treatment center for internet addiction is launching in Fall City, Washington.

Melanoma can occur in animals and accounts for 7 percent of malignant tumors in dogs.

The median survival time for dogs with advanced oral melanoma is less than 5 months.

A new animal vaccine incorporates human DNA to fight oral melanoma in dogs.

By studying melanoma treatments in animals, scientists may one day gain a better understanding of cancer in people and come up with better ways to detect or treat human cancers.

Researchers are examining whether laser beams stimulate blood flow to the scalp of chemotherapy patients. Developers say the extra blood flow increases cell metabolism and enables damaged blood vessels and cells in the hair follicles to regenerate. The healthier hair follicle should then be able to support new hair growth.

This year, 219,449 new cases will be diagnosed in the U.S.

70 percent of lung cancer patients aren’t diagnosed until the disease has spread.

Only 15 percent of patients are still alive five years after diagnosis.

Researchers are testing a vaccine, called Lucanix™, to see if it can prevent or delay recurrence of lung cancer in patients with advanced disease.

Researchers have found a new way to isolate specific subsets of breast cancer in a biopsy, a test that just might save a woman unneeded treatments to cure that cancer. The new test could eliminate the need for chemo or radiation therapy, or any aggressive treatment at all in some patients.

A product originally developed as a possible way to treat battlefield injuries is now part of an anti-aging treatment.

Breakthrough breast cancer research is giving one Delaware woman another chance at life. Doctors say the treatment brought amazing results in just a matter of months.

It could be a new way for women to enhance their love lives, and a group of Chicago area women is among the first in the nation to test it. Libigel is a testosterone based treatment, and if the trials are successful and Biosante Pharmaceuticals gets government approval, it would be the first FDA approved drug to boost desire in women.

Patients with Lyme disease often spend years searching for an accurate diagnosis.